Imperial Receives Recognition for Sustainability Performance!

Learn More

Imperial Clinical Research Services Blog
  • Services
    • What We Do
    • Study and Site Print Materials
    • Clinical Trial Translation Management
    • Ancillary Trial Supplies and Equipment
    • Clinical Trial Patient Engagement
    • CRO-Centered Services
    • A La Carte Services
  • Resources
    • Ebooks
    • Case Studies & Fact Sheets
  • About
    • About Us
    • News
    • Events
    • Corporate Responsibility
  • Contact
    • Contact Imperial
    • Career Opportunities
  • Blog
  • Marketplace
  • Services
    • What We Do
    • Study and Site Print Materials
    • Clinical Trial Translation Management
    • Ancillary Trial Supplies and Equipment
    • Clinical Trial Patient Engagement
    • CRO-Centered Services
    • A La Carte Services
  • Resources
    • Ebooks
    • Case Studies & Fact Sheets
  • About
    • About Us
    • News
    • Events
    • Corporate Responsibility
  • Contact
    • Contact Imperial
    • Career Opportunities
  • Blog
  • Marketplace
Author

Dan McDonald

Dan McDonald

Dan is vice president, business development, Imperial Clinical Research Services. Dan is a seasoned executive who specializes in identifying income opportunities, building strategic partnerships, and managing contract negotiations. A prolific and popular thought leader, Dan has presented at numerous industry conferences and events, has conducted workshops and sessions on patient engagement, and has been published numerous times in industry books, trade magazines, and journals.

    Imperial Bridging Gaps in Study Conduct at DIA
    Life-Science Events

    Bridging the Gaps in Study Conduct

    by Dan McDonald June 12, 2019
    written by Dan McDonald

    Today’s Challenges

    There are some amazing things happening in the field of clinical research right now. The hottest topics at the conferences I’ve attended over the past 18 months have been those focused on disruptive innovations. All of the data points to trials becoming increasingly complex; from the number of procedures, to the geographic footprint, to the burden of proof required. We have all seen it.

    The number of trials in rare and orphan indications, as well as oncology, including rare types of cancer – has exploded. These are challenging studies and innovative companies are emerging to help meet that demand. Big data, virtual trials, risk-based monitoring, the use of artificial intelligence, etc. — it’s all very exciting. It’s also a very small, arguably tiny fraction of all trials taking place. In most of the terrific stories you hear, such advancements don’t reflect critical mass. And, clinical operations teams often face big hurdles internally when introducing change. The future is bright, but the present is very challenging. Let’s talk about how Imperial is helping firms like yours address the most common and disruptive challenges.

    Industry metrics communicate clear trends where there are still issues with various critical elements of study conduct. The time required to take new compounds from the bench to the bedside is taking longer than ever.

    Reports on trends in study conduct activities across the industry have almost become predictable. Time and again, the survey findings that fuel these reports point to things like regulatory challenges, delays in contracting, delays in site initiation, delays in enrollment, attrition problems, and supply chain issues. The same culprits, again and again!

    Our business development teams and operations teams here at Imperial are regularly meeting with clinical operations teams at sponsors and CROs across North America and Europe. Without a doubt, the issues we hear that clinical teams are challenged by the most include:

    • Delayed site initiation and first patient in
    • Not meeting enrollment timelines and targets
    • Losing ground with compliance and attrition issues
    • Struggling with the complexities of increasingly global trials      

    Patient Engagement

    Think about the function of patient recruitment and retention — what we refer to today as patient engagement. It’s a critical function of study conduct support and one where many organizations have struggled. During the late 1990s and throughout the 2000s, patient recruitment agencies arose and came to prominence. The topic of proactive patient recruitment was a novel one, and these agencies led the charge in educating the drug development industry about the importance of such an approach. They carved out a unique service category niche and they thrived.

    Eventually — and essentially — the industry embraced the need for proactive recruitment and retention strategies to occur as early in the study planning process as possible. The concept is not novel anymore. Sponsor study teams develop their own strategies and determine what approaches they want to find, enroll, and keep patients in studies.

    Today, this gap in the market is fulfilled by service providers who understand and can deliver the select set of services that sponsors want to meet a particular need. A study brand. A study website. Recruitment materials. Written, translated, formatted, designed, printed or digitally produced in one place. It’s one of the gaps we are helping to bridge here at Imperial. We plug in and often act as the backroom engine behind these bright study teams and the strategic approach they have chosen for driving enrollment.

    There are similar stories for the issues of on-time study startup, site initiation visits, and first patient in. Stories of dealing with the complexities of global trials, such as challenges with supply chain, language, and logistics, etc. — those are stories for another time.

    If you’d like to hear more and discuss how Imperial is bridging these critical gaps in study conduct, please come speak with us at the 2019 DIA Annual Meeting. You can find us at Booth 1812 (AND you could win a gorgeous Coach Ava tote!). We look forward to seeing you!

    June 12, 2019 0 comment
    0 FacebookTwitterLinkedinEmail
  • Life-Science Events

    Tackling A Clinical Research Challenge Head-On at the 2019 Bridging Clinical Research & Clinical Health Care Conference

    by Dan McDonald March 20, 2019
    by Dan McDonald March 20, 2019

    For the second year in a row, clinical research executives gathered in the nation’s capital to discuss one of the biggest challenges tormenting the industry – how to improve the number of patients and physicians participating in clinical research. It’s an age old problem and…

    0 FacebookTwitterLinkedinEmail
  • Life-Science Events

    Tech Buzzes and Execution Beckons at SCOPE 2019

    by Dan McDonald March 6, 2019
    by Dan McDonald March 6, 2019

    The Summit for Clinical Ops Executives, or SCOPE as most know it, returned to Orlando this year. Held at the Hyatt Regency Orlando, on the famed but increasingly overcrowded International Drive, the conference ran from February 18-21. (Seriously, it’s becoming Vegas for families. If you…

    0 FacebookTwitterLinkedinEmail
  • Business Insights

    Report from Montreal: Operational Excellence in Clinical Trials Summit

    by Dan McDonald October 4, 2018
    by Dan McDonald October 4, 2018

    At the Operational Excellence in Clinical Trials Summit meeting in Montreal in September, I had the privilege to serve as keynote speaker and a panelist for several discussions. The conference brought together industry thought leaders in the area of patient engagement, study feasibility, and clinical…

    0 FacebookTwitterLinkedinEmail
  • Ancillary Trial Supplies and EquipmentBusiness InsightsLife-Science EventsPatient Recruitment and Retention

    Bridging Research and Health Care: If We Don’t Do it, Someone Else Will

    by Dan McDonald May 21, 2018
    by Dan McDonald May 21, 2018

    I recently had the honor and privilege of representing Imperial at the inaugural Bridging Clinical Research and Clinical Health Care conference in National Harbor, Maryland. It was interesting and worthwhile. The conference brought together heavy hitters and important voices, including the FDA and advocates from…

    0 FacebookTwitterLinkedinEmail
  • Business InsightsLife-Science Events

    3 Ways to Outsmart the Big Dogs as You Move into the Clinic

    by Dan McDonald February 23, 2018
    by Dan McDonald February 23, 2018

    You’ve done all the background work. You’ve navigated the complex U.S. regulatory environment and achieved investigational new drug approval. You’ve secured investors and assembled your core team. You are now preparing for the next big milestone for your burgeoning biopharmaceutical company – entering the clinic.…

    0 FacebookTwitterLinkedinEmail
  • Life-Science EventsPatient Recruitment and Retention

    The Role of Patient Engagement in the Transition from Lab to Clinic

    by Dan McDonald January 17, 2018
    by Dan McDonald January 17, 2018

    The drug discovery and development process is a complex and challenging landscape, especially for the majority of small biopharmaceutical and medical device companies. It’s truly a survival of the fittest environment, fraught with potential pitfalls and company killers. For every Kite Pharma (acquired by Gilead…

    0 FacebookTwitterLinkedinEmail
  • Patient Recruitment and Retention

    Do We Have a Performance Measurement Problem in Clinical Trial Patient Recruitment?

    by Dan McDonald March 17, 2017
    by Dan McDonald March 17, 2017

    It’s fairly well accepted in today’s clinical research environment that proactive strategies for driving enrollment in clinical trials are part of the complicated equation of success. According to a 2016 survey of study sponsors conducted by Imperial, nearly 55 percent of sponsors develop formal recruitment…

    0 FacebookTwitterLinkedinEmail
  • Patient Recruitment and Retention

    The Facts on Patient Enrollment Delays

    by Dan McDonald March 2, 2017
    by Dan McDonald March 2, 2017

    The Undeniable Truth Everyone is aware that patient enrollment is an issue. In a recent report from Tufts Center for the Study of Drug Development on 150 global trials, it was discovered that 9 out of 10 studies eventually achieved enrollment goals, but that it…

    0 FacebookTwitterLinkedinEmail
  • Business InsightsPatient Recruitment and Retention

    Behind the Scenes at Trial Sponsor Companies Part 2: Enrollment Plans, Strategies, and Metrics

    by Dan McDonald October 19, 2016
    by Dan McDonald October 19, 2016

    In my last blog post, I wrote about findings from a first-of-its kind survey conducted by Imperial. We surveyed managers and directors of clinical operations, project managers, lead/senior CRAs, and patient recruitment specialists from sponsor companies, and ended up with a behind the scenes look…

    0 FacebookTwitterLinkedinEmail
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6

Welcome

Welcome

The Imperial blog features content of interest to life-science professionals, with a special focus on clinical trials. We hope you will enjoy our experts’ perspectives, and invite you to join the conversation by leaving your comments. Please let us know of any additional topics you would like to see covered here.

Signup for our Blog Subscription

Signup for our Blog Subscription

Keep in touch

Twitter Linkedin Youtube Email RSS

Popular Posts

  • 1

    Clinical Research Phases and the Path to Drug Approval

    August 8, 2023
  • 2

    See Do Get

    August 12, 2014
  • 3

    Google Translate: The Unwitting Confidentiality Flaw

    April 15, 2020
  • 4

    25 Reasons People Aren’t Enrolling in Your Clinical Trial

    October 29, 2015
  • 5

    The Upcoming FDA Clinical Trial Diversity Mandate: What You Need to Know

    May 14, 2025

Categories

  • Ancillary Trial Supplies and Equipment (35)
  • Business Insights (133)
  • Clinical Trial Writing and Design (41)
  • Life-Science Events (58)
  • Patient Engagement (39)
  • Patient Recruitment and Retention (100)
  • Site Materials & Logistics (50)
  • Study Site Management (22)
  • Translation of Study Materials (18)
Imperial Clinical Research Services Blog

Imperial is a global leader in clinical trial solutions and support, specializing in study and site print materials, ancillary trial supplies and equipment, clinical trial translation management, and clinical trial patient engagement.

Imperial CRS Corporate Headquarters
3100 Walkent Drive NW
Grand Rapids, MI 49544

Contact

connect@imperialcrs.com

800.777.2591

020 3887 3437

Employment

Social

We Run on EOS - Entrepreneurial Operating SystemEcovadis Sustainability Rating January 2024West Michigan's Best and Brightest Companies to Work For Winner 2025The Best and Brightest Companies to Work For Logo
© Imperial CRS, LLC | Privacy Policy
Signup for our Blog Subscription

Subscribe to our blog and get the latest updates, insights, and industry trends delivered straight to your inbox. Stay informed and never miss a post.